Mumbai, Aug 28 (SocialNews.XYZ) The Maharashtra Food and Drug Administration (FDA) has cancelled the drug sale licences of Cipla Pharma & Life Sciences Ltd's Carry and Forwarding (C&F) facility at Wadki in Pune, due to serious irregularities found during inspections related to the company's Reactin Plus tablets. During the inspection in June, FDA officials found unauthorised promotional text on the packaging of Reactin Plus, a Schedule H prescription medicine. The words "analgesic and antipyretic" were found on the packaging. The regulator seized Reactin Plus stock worth over Rs 11 lakh and ordered the firm to recall the drug from the market, citing packaging violations as per the provisions of the Drugs and Cosmetics Act, 1940 and Rules, 1945.

Mumbai, Aug 14 (SocialNews.XYZ) The Maharashtra Food and Drug Administration (FDA) has suspended 14 food business licences after conducting a statewide inspection drive targeting food establishments operating through quick-commerce and online food delivery platforms, including Blinkit, Zepto, and Instamart. The special inspection drive was conducted on Thursday, during which FDA officials inspected 86 establishments across Maharashtra. Besides suspending 14 licences, the regulator ordered one establishment to temporarily stop operations and issued 60 improvement notices. No food business licence was cancelled as part of the drive. Of the 14 suspended licences, five each were linked to Blinkit and Zepto facilities, while two were associated with Instamart.